Diagnostic Deals - G2 Intelligence

Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males

More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.

Start a Free Trial for immediate access to this article

Already a member? Log in here

An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.

Start a Free Trial for immediate access to this article

Already a member? Log in here

While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.

Start a Free Trial for immediate access to this article

Already a member? Log in here

As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.

Start a Free Trial for immediate access to this article

Already a member? Log in here